Inflammation News and Research

RSS

New polysaccharide may help combat multidrug resistance in cancer

In a recent study published in the Journal of Biological Chemistry, scientists report that a molecule previously thought to play a purely structural and inert role in cells is actually involved in multidrug resistance in cancer.

22 May 2005

Allergies increase risk for corneal transplant rejection

Corneal transplant patients who suffer from eye allergies are at a significantly higher risk of transplant failure than those without allergies, UT Southwestern Medical Center researchers have shown.

22 May 2005

Bacteria in plaque may increase risk for heart attacks

Researchers have found evidence that the amount of bacteria in subgingival plaques, the deep plaques in periodontal pockets and around the teeth, may contribute to an individual's risk of a heart attack, according to two studies appearing the Journal of Periodontology.

20 May 2005

Researchers prevent post-traumatic brain damage using experimental drug

In animal studies, researchers from Georgetown University Medical Center have shown how traumatic brain injury leads to loss of brain function - and found that an experimental drug can stop the damage and promote recovery.

18 May 2005

Routine, inexpensive blood test sharpens heart disease risk predictions

Routine measurements of white blood cell counts that provide a ratio of neutrophils to lymphocytes may offer a simple and low-cost way to refine predictions of heart attack or death, according to a new study in the May 17, 2005, issue of the Journal of the American College of Cardiology.

18 May 2005

Bioniche granted additional patent for mycobacterial cell wall technology

Bioniche Life Sciences Inc., a research-based, technology-driven human and animal health biopharmaceutical company, today announced that it has had a new patent issued by the United States Patent and Trademark Office (USPTO) on its core mycobacterial cell wall technology.

18 May 2005

Breast cancer chemotherapy regimen associated with life-threatening complications

The chemotherapy regimen of doxorubicin plus docetaxel, used to treat breast cancer in a clinical trial, was associated with an increased risk of serious complications, resulting in the premature termination of the trial, according to a study in the May 18 issue of JAMA.

17 May 2005

Gluten exposure at 4 to 6 months of age lowers risk of celiac disease

Children with gluten exposure from cereal grains at 4 to 6 months of age have a lower risk of celiac disease than children with exposure before or after this time period, according to a study in the May 18 issue of JAMA.

17 May 2005

Grapefruit have strong antioxidant properties that can have healing effects on stomach ulcers

Extracts of the popular diet item grapefruit have strong antioxidant properties that can have healing effects on stomach ulcers, according to a new study presented today at Digestive Disease Week 2005 (DDW).

17 May 2005

Doxorubicin-docetaxel combination is associated with an increased risk of severe and life-threatening complications

Researchers in France say a study using two chemotherapy agents to treat breast cancer was halted after two women in the study died.

17 May 2005

Association between maternal exposure to toxoplasmosis and increased risk for developing schizophrenia

Toxoplasmosis is a parasitic infection that can develop from eating undercooked meat and unwashed fruits and vegetables, drinking contaminated water, or not washing one's hands after gardening or changing cat litter boxes. Researchers found a potential link between high maternal toxoplasmosis gondii antibody titers and development of schizophrenia spectrum disorders in the adult offspring.

16 May 2005

Improvements in critical care decrease risk of post-injury multiple organ failure

Improvements in critical care and decreased use of blood transfusions over the course of the last decade are associated with decreases in the rate, severity and risk of death from post-injury multiple organ failure, according to a study in the May issue of Archives of Surgery.

16 May 2005

Disabling gene defuses rheumatoid arthritis in mice

Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

16 May 2005

Unsuspected protein CD147, regulates the production of plaque-forming peptides that are the defining feature of Alzheimer's

Researchers at the Department of Energy's Lawrence Berkeley National Laboratory have discovered an unsuspected subunit of the protein complex gamma-secretase, which plays a central role in Alzheimer's disease.

15 May 2005

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Recent studies of a new anticancer drug show continued response for patients with late-stage kidney cancer. Robert Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), reported a response rate of 40 percent in patients with metastatic (advanced) renal cell (kidney) cancer who received SU11248 in second-line therapy.

15 May 2005

Miserable mumps makes a comeback

There is concern in the UK at the growing number of outbreaks of mumps among children and young people.

12 May 2005

Researchers identify mechanism which increases lung inflammation, making Chronic Obstructive Pulmonary Disorder (COPD) more severe

An international team of researchers has identified a mechanism which increases lung inflammation, making Chronic Obstructive Pulmonary Disorder (COPD) more severe, and potentially points towards new treatments.

11 May 2005

Common antibiotic called minocycline may slow or prevent diabetic retinopathy

The team found that minocycline, often used to treat acne, limits by about 50 percent the retinal damage caused by microglia. Microglia are cells that act as the "cleanup crew" for the Central Nervous System (CNS).

11 May 2005

Drug lowers inflammatory markers associated with risk for heart attack

A preliminary study suggests that use of a drug that inhibits a specific protein in patients with certain genetic variants that increase their risk for heart attack reduced their levels of inflammatory markers associated with heart attack risk, according to a study in the May 11 issue of JAMA.

10 May 2005

Broken bones may reduce risk of ovarian cancer

The pain and suffering of a broken bone may yield an unexpected benefit – a reduced risk of ovarian cancer.

10 May 2005

Inflammation News and Research

New polysaccharide may help combat multidrug resistance in cancer

Allergies increase risk for corneal transplant rejection

Bacteria in plaque may increase risk for heart attacks

Researchers prevent post-traumatic brain damage using experimental drug

Routine, inexpensive blood test sharpens heart disease risk predictions

Bioniche granted additional patent for mycobacterial cell wall technology

Breast cancer chemotherapy regimen associated with life-threatening complications

Gluten exposure at 4 to 6 months of age lowers risk of celiac disease

Grapefruit have strong antioxidant properties that can have healing effects on stomach ulcers

Doxorubicin-docetaxel combination is associated with an increased risk of severe and life-threatening complications

Association between maternal exposure to toxoplasmosis and increased risk for developing schizophrenia

Improvements in critical care decrease risk of post-injury multiple organ failure

Disabling gene defuses rheumatoid arthritis in mice

Unsuspected protein CD147, regulates the production of plaque-forming peptides that are the defining feature of Alzheimer's

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Miserable mumps makes a comeback

Researchers identify mechanism which increases lung inflammation, making Chronic Obstructive Pulmonary Disorder (COPD) more severe

Common antibiotic called minocycline may slow or prevent diabetic retinopathy

Drug lowers inflammatory markers associated with risk for heart attack

Broken bones may reduce risk of ovarian cancer

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News